Copyright
©2014 Baishideng Publishing Group Inc.
World J Diabetes. Dec 15, 2014; 5(6): 951-961
Published online Dec 15, 2014. doi: 10.4239/wjd.v5.i6.951
Published online Dec 15, 2014. doi: 10.4239/wjd.v5.i6.951
Table 2 Outcomes in African-American vs non-African-American recipients
| AA | Non-AA | P value | |
| n = 39 | n = 1631 | ||
| Patient survival | 35 (89.7%) | 141 (86.5%) | NS |
| Death with functioning grafts | 1 (2.6%) | 14 (8.6%) | NS |
| Kidney graft survival | 26 (66.7%) | 123/159 (77.4%) | NS |
| Death-censored kidney graft survival | 26/37 (70%) | 123/143 (87%) | 0.03 |
| Pancreas graft survival | 23 (59%) | 108 (66.3%) | NS |
| Death-censored pancreas graft survival | 23/37 (62%) | 108/148 (73%) | NS |
| Death-censored dual graft loss | 8/37 (21.6%) | 9/142 (6.3%) | 0.01 |
| Follow-up (mo) | 64.9 ± 38.2 | 69.8 ± 28.6 | NS |
| Relaparotomy | 18 (46.2%) | 58 (35.6%) | NS |
| Early thrombosis | 4 (10.3%) | 12 (7.4%) | NS |
| Acute rejection | 13 (33.3%) | 44 (27.0%) | NS |
- Citation: Rogers J, Farney AC, Orlando G, Iskandar SS, Doares W, Gautreaux MD, Kaczmorski S, Reeves-Daniel A, Palanisamy A, Stratta RJ. Pancreas transplantation: The Wake Forest experience in the new millennium. World J Diabetes 2014; 5(6): 951-961
- URL: https://www.wjgnet.com/1948-9358/full/v5/i6/951.htm
- DOI: https://dx.doi.org/10.4239/wjd.v5.i6.951